These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19282174)

  • 21. Influence of fluoxetine and litoxetine on 5-HT4 receptor-mediated relaxation in the rat isolated oesophagus.
    Lucchelli A; Santagostino-Barbone MG; Masoero E; Baiardi P; Tonini M
    Fundam Clin Pharmacol; 1999; 13(3):330-6. PubMed ID: 10392309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of 1-(4-(piperazin-1-yl)phenyl)pyridin-2(1H)-one derivatives as potential SSRIs.
    Xu T; Xue Y; Lu J; Jin C
    Eur J Med Chem; 2021 Nov; 223():113644. PubMed ID: 34182358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.
    Wakenhut F; Fish PV; Fray MJ; Gurrell I; Mills JE; Stobie A; Whitlock GA
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4308-11. PubMed ID: 18625557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of peptide combinatorial libraries in drug design: the identification of a potent serotonin reuptake inhibitor derived from a tripeptide cassette library.
    Koppel G; Dodds C; Houchins B; Hunden D; Johnson D; Owens R; Chaney M; Usdin T; Hoffman B; Brownstein M
    Chem Biol; 1995 Jul; 2(7):483-7. PubMed ID: 9383450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.
    Vu AT; Cohn ST; Terefenko EA; Moore WJ; Zhang P; Mahaney PE; Trybulski EJ; Goljer I; Dooley R; Bray JA; Johnston GH; Leiter J; Deecher DC
    Bioorg Med Chem Lett; 2009 May; 19(9):2464-7. PubMed ID: 19329313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Design, synthesis and 5-HT/NE dual reuptake inhibitory activity of aromatic heterocyclic arylamidine derivatives].
    Wen H; Yang J; Zhang JJ; Wang YF; Ji CX; Yang GZ
    Yao Xue Xue Bao; 2009 Mar; 44(3):303-8. PubMed ID: 19449528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.
    Fish PV; Deur C; Gan X; Greene K; Hoople D; Mackenny M; Para KS; Reeves K; Ryckmans T; Stiff C; Stobie A; Wakenhut F; Whitlock GA
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2562-6. PubMed ID: 18387300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SAR development of a selective 5-HT1D antagonist/serotonin reuptake inhibitor lead using rapid parallel synthesis.
    Timms GH; Boot JR; Broadmore RJ; Carney SL; Cooper J; Findlay JD; Gilmore J; Mitchell S; Moore NA; Pullar I; Sanger GJ; Tomlinson R; Tree BB; Wedley S
    Bioorg Med Chem Lett; 2004 May; 14(10):2469-72. PubMed ID: 15109634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and activity of a new class of dual acting norepinephrine and serotonin reuptake inhibitors: 3-(1H-indol-1-yl)-3-arylpropan-1-amines.
    Mahaney PE; Vu AT; McComas CC; Zhang P; Nogle LM; Watts WL; Sarkahian A; Leventhal L; Sullivan NR; Uveges AJ; Trybulski EJ
    Bioorg Med Chem; 2006 Dec; 14(24):8455-66. PubMed ID: 16973367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.
    Deskus JA; Epperson JR; Sloan CP; Cipollina JA; Dextraze P; Qian-Cutrone J; Gao Q; Ma B; Beno BR; Mattson GK; Molski TF; Krause RG; Taber MT; Lodge NJ; Mattson RJ
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3099-104. PubMed ID: 17391962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter targeting potential agents for Alzheimer's disease.
    Kogen H; Toda N; Tago K; Marumoto S; Takami K; Ori M; Yamada N; Koyama K; Naruto S; Abe K; Yamazaki R; Hara T; Aoyagi A; Abe Y; Kaneko T
    Org Lett; 2002 Oct; 4(20):3359-62. PubMed ID: 12323018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties.
    Angel I; Schoemaker H; Prouteau M; Garreau M; Langer SZ
    Eur J Pharmacol; 1993 Mar; 232(2-3):139-45. PubMed ID: 8385615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformationally restricted homotryptamines. Part 6: indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.
    Ditta JL; Denhart DJ; Deskus JA; Epperson JR; Meng Z; Gao Q; Mattson GK; Lapaglia MA; Taber MT; Molski TF; Lodge NJ; Mattson RJ; Macor JE
    Bioorg Med Chem Lett; 2013 May; 23(10):2948-50. PubMed ID: 23578689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3 Beta-(4-ethyl-3-iodophenyl)nortropane-2 beta-carboxylic acid methyl ester as a high-affinity selective ligand for the serotonin transporter.
    Blough BE; Abraham P; Mills AC; Lewin AH; Boja JW; Scheffel U; Kuhar MJ; Carroll FI
    J Med Chem; 1997 Nov; 40(24):3861-4. PubMed ID: 9397165
    [No Abstract]   [Full Text] [Related]  

  • 35. [Design, synthesis and pharmacological investigation of isoindoline derivatives as 5-HT/NE double reuptake inhibitors].
    Wen H; Shi Y; Dong JW; Guo YS; Zang JJ; Yang GZ
    Yao Xue Xue Bao; 2015 Sep; 50(9):1148-55. PubMed ID: 26757552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3,4-Dihydro-2H-benzoxazinones are 5-HT(1A) receptor antagonists with potent 5-HT reuptake inhibitory activity.
    Atkinson PJ; Bromidge SM; Duxon MS; Gaster LM; Hadley MS; Hammond B; Johnson CN; Middlemiss DN; North SE; Price GW; Rami HK; Riley GJ; Scott CM; Shaw TE; Starr KR; Stemp G; Thewlis KM; Thomas DR; Thompson M; Vong AK; Watson JM
    Bioorg Med Chem Lett; 2005 Feb; 15(3):737-41. PubMed ID: 15664848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reviewing the serotonin reuptake inhibitors (SSRIs) footprint in the aquatic biota: uptake, bioaccumulation and ecotoxicology.
    Silva LJG; Pereira AMPT; Meisel LM; Lino CM; Pena A
    Environ Pollut; 2015 Feb; 197():127-143. PubMed ID: 25528447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of PSSRI-based inhibitors of Staphylococcus aureus multidrug efflux pumps.
    German N; Kaatz GW; Kerns RJ
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1368-73. PubMed ID: 18242086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.
    Voelker T; Xia H; Fandrick K; Johnson R; Janowsky A; Cashman JR
    Bioorg Med Chem; 2009 Mar; 17(5):2047-68. PubMed ID: 19201198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies towards the next generation of antidepressants. Part 4: derivatives of 4-(5-fluoro-1H-indol-3-yl)cyclohexylamine with affinity for the serotonin transporter and the 5-HT1A receptor.
    Evrard DA; Zhou P; Yi SY; Zhou D; Smith DL; Sullivan KM; Hornby GA; Schechter LE; Andree TH; Mewshaw RE
    Bioorg Med Chem Lett; 2005 Feb; 15(4):911-4. PubMed ID: 15686885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.